Concepedia

Jianxin Yang

JY

8

Publications

271

Citations

8

H-Index

2015

Active since

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Monash Health

BeiGene (China)

Monash University

Jianxin Yang is an author at Peter MacCallum Cancer Centre specializing in tumor microenvironment, systems biology, and tumor biology.

ORCID

Top concepts

Publications per year

2015–2022

8

Publications

8

The BTK Inhibitor, Bgb-3111, Is Safe, Tolerable, and Highly Active in Patients with Relapsed/ Refractory B-Cell Malignancies: Initial Report of a Phase 1 First-in-Human Trial

Constantine S. Tam, Andrew Grigg, Stephen Opat et al. · Blood · 2015 · 111 citations

Calcium-Binding Proteins S100A8 and S100A9: Investigation of Their Immune Regulatory Effect in Myeloid Cells

Jianxin Yang, Jacqueline D.H. Anholts, Ulrike Kolbe et al. · International Journal of Molecular Sciences · 2018 · 48 citations · Full text

Twice Daily Dosing with the Highly Specific BTK Inhibitor, Bgb-3111, Achieves Complete and Continuous BTK Occupancy in Lymph Nodes, and Is Associated with Durable Responses in Patients (pts) with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Constantine S. Tam, Stephen Opat, Gavin Cull et al. · Blood · 2016 · 36 citations

Safety, antitumor activity and biomarkers of sugemalimab in Chinese patients with advanced solid tumors or lymphomas: results from the first-in-human phase 1 trial

Jifang Gong, Junning Cao, Qingyuan Zhang et al. · Cancer Immunology Immunotherapy · 2022 · 21 citations · Full text

The source of SYBR green master mix determines outcome of nucleic acid amplification reactions

Jianxin Yang, Berit Kemps-Mols, Marijke Spruyt-Gerritse et al. · BMC Research Notes · 2016 · 16 citations · Full text

Rows per page

1–5 of 8